These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 34775124)

  • 21. Cyclic amplification of intracellular ROS boosts enzymatic prodrug activation for enhanced chemo-immunotherapy.
    Liu Y; Jiang M; Zhao Z; Wang N; Wang K; Yuan Y
    Acta Biomater; 2023 Aug; 166():567-580. PubMed ID: 37207741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis.
    Xu Z; Li Q; Zhang C; Wang P; Xu X; Ran L; Zhang L; Tian G; Zhang G
    Nanoscale; 2022 Aug; 14(32):11600-11611. PubMed ID: 35861683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Strategy of Fenton Reaction Cycloacceleration for High-Performance Ferroptosis Therapy Initiated by Tumor Microenvironment Remodeling.
    Huang L; Feng J; Zhu J; Yang J; Xiong W; Lu X; Chen S; Yang S; Li Y; Xu Y; Shen Z
    Adv Healthc Mater; 2023 Jul; 12(18):e2203362. PubMed ID: 36893770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
    Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
    Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy.
    Chen M; Tong X; Sun Y; Dong C; Li C; Wang C; Zhang M; Wen Y; Ye P; Li R; Wan J; Liang S; Shi S
    Biomaterials; 2024 Sep; 309():122574. PubMed ID: 38670032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An iron oxyhydroxide-based nanosystem sensitizes ferroptosis by a "Three-Pronged" strategy in breast cancer stem cells.
    Wu K; Zhang W; Chen H; Wu J; Wang X; Yang X; Liang XJ; Zhang J; Liu D
    Acta Biomater; 2023 Apr; 160():281-296. PubMed ID: 36822484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pH-activated nanoplatform for visualized photodynamic and ferroptosis synergistic therapy of tumors.
    Sun R; Ma W; Ling M; Tang C; Zhong M; Dai J; Zhu M; Cai X; Li G; Xu Q; Tang L; Yu Z; Peng Z
    J Control Release; 2022 Oct; 350():525-537. PubMed ID: 36055597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-Assembled Copper-Based Nanoparticles for Glutathione Activated and Enzymatic Cascade-Enhanced Ferroptosis and Immunotherapy in Cancer Treatment.
    Song WF; Zeng JY; Ji P; Han ZY; Sun YX; Zhang XZ
    Small; 2023 Aug; 19(35):e2301148. PubMed ID: 37118853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
    Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
    J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redox Responsive Metal Organic Framework Nanoparticles Induces Ferroptosis for Cancer Therapy.
    He H; Du L; Guo H; An Y; Lu L; Chen Y; Wang Y; Zhong H; Shen J; Wu J; Shuai X
    Small; 2020 Aug; 16(33):e2001251. PubMed ID: 32677157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A ferroptosis-reinforced nanocatalyst enhances chemodynamic therapy through dual H
    Zhu XY; Wang TY; Jia HR; Wu SY; Gao CZ; Li YH; Zhang X; Shan BH; Wu FG
    J Control Release; 2024 Mar; 367():892-904. PubMed ID: 38278369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bovine serum albumin-templated nanoplatform for magnetic resonance imaging-guided chemodynamic therapy.
    Tang W; Gao H; Ni D; Wang Q; Gu B; He X; Peng W
    J Nanobiotechnology; 2019 May; 17(1):68. PubMed ID: 31109332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cycloacceleration of Reactive Oxygen Species Generation Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for Tumor Ferroptosis Therapy.
    Zhou H; Lu X; Du C; Zhou Z; Feng J; Liang Z; Xu Y; Qiu X; Shen Z
    Small; 2022 Sep; 18(35):e2202705. PubMed ID: 35923138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy.
    Yang J; Ma S; Xu R; Wei Y; Zhang J; Zuo T; Wang Z; Deng H; Yang N; Shen Q
    J Control Release; 2021 Jun; 334():21-33. PubMed ID: 33872626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyaluronic Acid-Modified Spherical MgO
    Xie W; Lu Y; Yuan Y; Xiao L; Liu J; Song H; Niu R; Liu Y; Lin J
    ACS Biomater Sci Eng; 2024 Aug; 10(8):5226-5236. PubMed ID: 38943566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanocatalytic theranostics with intracellular mutual promotion for ferroptosis and chemo-photothermal therapy.
    Zhang M; Chen Y; Wang Q; Li C; Yuan C; Lu J; Luo Y; Liu X
    J Colloid Interface Sci; 2024 Mar; 657():619-631. PubMed ID: 38071811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An active-passive strategy for enhanced synergistic photothermal-ferroptosis therapy in the NIR-I/II biowindows.
    Wu F; Chen H; Liu R; Suo Y; Li Q; Zhang Y; Liu H; Cheng Z; Chang Y
    Biomater Sci; 2022 Feb; 10(4):1104-1112. PubMed ID: 35044388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifunctional nanolocks with GSH as the key for synergistic ferroptosis and anti-chemotherapeutic resistance.
    Zhu J; Wang X; Su Y; Shao J; Song X; Wang W; Zhong L; Gan L; Zhao Y; Dong X
    Biomaterials; 2022 Sep; 288():121704. PubMed ID: 35948496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator.
    He YJ; Liu XY; Xing L; Wan X; Chang X; Jiang HL
    Biomaterials; 2020 May; 241():119911. PubMed ID: 32143060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
    Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
    Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.